Antibiotics Stimulate Formation of Vesicles in
Anti-Bacterial Agents
/ pharmacology
Bacteriophages
/ physiology
Cephalosporins
/ pharmacology
Cytoplasmic Vesicles
/ drug effects
DNA, Bacterial
/ drug effects
Daptomycin
/ pharmacology
Floxacillin
/ pharmacology
Humans
Lysogeny
/ genetics
Peptidoglycan
/ drug effects
Staphylococcus aureus
/ drug effects
Ceftaroline
Staphylococcus aureus
antibiotics
bacteriophages
membrane vesicles
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
12
07
2018
accepted:
18
11
2018
pubmed:
5
12
2018
medline:
6
2
2020
entrez:
5
12
2018
Statut:
epublish
Résumé
Bacterial membrane vesicle research has so far focused mainly on Gram-negative bacteria. Only recently have Gram-positive bacteria been demonstrated to produce and release extracellular membrane vesicles (MVs) that contribute to bacterial virulence. Although treatment of bacteria with antibiotics is a well-established trigger of bacterial MV formation, the underlying mechanisms are poorly understood. In this study, we show that antibiotics can induce MVs through different routes in the important human pathogen
Identifiants
pubmed: 30509943
pii: AAC.01439-18
doi: 10.1128/AAC.01439-18
pmc: PMC6355553
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cephalosporins
0
DNA, Bacterial
0
Peptidoglycan
0
Floxacillin
43B2M34G2V
Daptomycin
NWQ5N31VKK
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
Microb Pathog. 2017 Sep;110:225-231
pubmed: 28687320
Nature. 1983 Oct 20-26;305(5936):709-12
pubmed: 6226876
J Bacteriol. 2007 Jan;189(2):531-9
pubmed: 17085555
mBio. 2018 Apr 10;9(2):
pubmed: 29636428
Nat Commun. 2018 Apr 11;9(1):1379
pubmed: 29643357
Nat Rev Microbiol. 2015 Oct;13(10):620-30
pubmed: 26324094
Front Microbiol. 2018 Feb 20;9:262
pubmed: 29515544
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
J Innate Immun. 2016;8(3):269-83
pubmed: 26934383
PLoS One. 2013 Sep 30;8(9):e77122
pubmed: 24098817
J Bacteriol. 1998 Oct;180(20):5478-83
pubmed: 9765585
Nat Commun. 2016 Apr 14;7:11220
pubmed: 27075392
J Med Microbiol. 1992 Feb;36(2):78-82
pubmed: 1740787
J Bacteriol. 2011 May;193(9):2332-5
pubmed: 21378186
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5957-67
pubmed: 27458233
Nat Microbiol. 2016 Oct 24;2:16194
pubmed: 27775684
BMC Microbiol. 2011 Dec 01;11:258
pubmed: 22133164
Mol Cell Proteomics. 2015 Aug;14(8):2138-49
pubmed: 26018414
J Basic Microbiol. 2015 Apr;55(4):509-13
pubmed: 25589010
mBio. 2013 Feb 12;4(1):e00537-12
pubmed: 23404398
Infect Genet Evol. 2013 Aug;18:299-308
pubmed: 23770143
Appl Environ Microbiol. 2013 Mar;79(6):1874-81
pubmed: 23315742
N Engl J Med. 1998 Aug 20;339(8):520-32
pubmed: 9709046
Nat Commun. 2017 Sep 7;8(1):481
pubmed: 28883390
Genome Announc. 2014 Mar 13;2(2):
pubmed: 24625873
Nat Rev Microbiol. 2019 Jan;17(1):13-24
pubmed: 30397270
PLoS Pathog. 2013;9(10):e1003620
pubmed: 24098113
J Hosp Infect. 2003 Sep;55(1):61-7
pubmed: 14505611
PLoS One. 2011;6(11):e27958
pubmed: 22114730
Antimicrob Agents Chemother. 2013 Jun;57(6):2589-95
pubmed: 23529736
PLoS One. 2011;6(7):e22299
pubmed: 21811583
Cell Microbiol. 2016 Nov;18(11):1525-1536
pubmed: 27673272
J Bacteriol. 1996 May;178(10):2767-74
pubmed: 8631663
Environ Microbiol. 2017 Oct;19(10):3930-3937
pubmed: 28488744
PLoS One. 2013;8(1):e54661
pubmed: 23382935
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7077-E7086
pubmed: 27791134
Microbiology. 2011 Mar;157(Pt 3):677-684
pubmed: 21183573